Literature DB >> 10813545

Skin permeation of testosterone and its ester derivatives in rats.

M K Kim1, C H Lee, D D Kim.   

Abstract

To establish the optimum conditions for improving the transdermal delivery of testosterone, we studied the relationship between the lipophilicity of testosterone ester derivatives and the rat skin permeation rate of testosterone. We performed a rat skin permeation study of testosterone and its commercially available ester derivatives, testosterone hemisuccinate, testosterone propionate and testosterone-17beta-cypionate, using an ethanol/water co-solvent system. The aqueous solubility and rat skin permeation rate of each drug, saturated in various compositions of an ethanol/water system, was determined at 37 degrees C. The aqueous solubility of testosterone and its ester derivatives increased exponentially as the volume fraction of ethanol increased up to 100% (v/v). The stability of testosterone propionate in both the skin homogenate and the extract was investigated to observe the enzymatic degradation during the skin permeation process. Testosterone propionate was found to be stable in the isotonic buffer solution and in the epidermis-side extract for 10h at 37 degrees C. However, in the skin homogenate and the dermis-side extract testosterone propionate rapidly degraded producing testosterone, implying that testosterone propionate rapidly degraded to testosterone during the skin permeation process. The steady-state permeation rates of testosterone in the ethanol/water systems increased exponentially as the volume fraction of ethanol increased, reaching the maximum value (2.69+/-0.69 microg cm(-2)h(-1)) at 70% (v/v) ethanol in water, and then decreasing with further increases in the ethanol volume fraction. However, in the skin permeation study with testosterone esters saturated in 70% (v/v) ethanol in water system, testosterone esters were hardly detected in the receptor solution, probably due to the rapid degradation to testosterone during the skin permeation process. Moreover, a parabolic relationship was observed between the permeation rate of testosterone and the log P values of ester derivatives. Maximum flux was achieved at a log P value of around 3 which corresponded to that of testosterone (log P = 3.4). The results showed that the skin permeation rate of testosterone and its ester derivatives was maximized when these compounds were saturated in a 70% ethanolic solution. It was also found that a log P value of around 3 is suitable for the skin permeation of testosterone related compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10813545     DOI: 10.1211/0022357001774101

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  Effect of direction (epidermis-to-dermis and dermis-to-epidermis) on the permeation of several chemical compounds through full-thickness skin and stripped skin.

Authors:  Takeshi Oshizaka; Hiroaki Todo; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2012-05-24       Impact factor: 4.200

Review 2.  Testosterone hormone replacement therapy: state-of-the-art and emerging technologies.

Authors:  Marie-Laure Leichtnam; Hervé Rolland; Patrick Wüthrich; Richard H Guy
Journal:  Pharm Res       Date:  2006-06-09       Impact factor: 4.200

3.  Skin solubility determines maximum transepidermal flux for similar size molecules.

Authors:  Qian Zhang; Jeffrey E Grice; Peng Li; Owen G Jepps; Guang-Ji Wang; Michael S Roberts
Journal:  Pharm Res       Date:  2009-06-05       Impact factor: 4.200

4.  Vehicle effects on the in vitro penetration of testosterone through equine skin.

Authors:  P C Mills
Journal:  Vet Res Commun       Date:  2006-12-26       Impact factor: 2.459

Review 5.  Transdermal Permeation of Drugs in Various Animal Species.

Authors:  Hiroaki Todo
Journal:  Pharmaceutics       Date:  2017-09-06       Impact factor: 6.321

6.  Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation.

Authors:  Rofida Albash; Aly A Abdelbary; Hanan Refai; Mohamed A El-Nabarawi
Journal:  Int J Nanomedicine       Date:  2019-03-15

7.  Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment.

Authors:  Rofida Albash; Mohamed A El-Nabarawi; Hanan Refai; Aly A Abdelbary
Journal:  Int J Nanomedicine       Date:  2019-08-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.